[Heparanase and vascular endothelial growth factor expression in non-small-cell lung cancer].

Objective: To study the clinicopathological significance of heparanase and VEGF expression in NSCLC.

Methods: Eighty-five lung samples were studied. Each sample was divided into two parts, one used for heparanase mRNA detection by reverse transcription PCR and the other for VEGF detection by immunohistochemistry.